What is Dr Livas?
Based in Lexington, Kentucky, Dr Livas operates as a premier medical facility dedicated to the comprehensive management of allergy, asthma, and immunological disorders. Under the clinical leadership of Dr. Iraklis Livas, the practice distinguishes itself through a patient-centric model that integrates advanced diagnostic testing with highly personalized therapeutic protocols. The clinic serves as a critical healthcare hub for the region, addressing the rising demand for specialized respiratory and immune system care. By prioritizing same-day accessibility and thorough clinical evaluations, the company has established a strong market presence, effectively bridging the gap between complex immunological research and practical, daily patient relief.
How much funding has Dr Livas raised?
Dr Livas has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Dr Livas
PPP
Public-Private Partnership
What's next for Dr Livas?
With the successful closure of this late-stage funding, Dr Livas is poised to enter a new phase of operational maturity. The strategic roadmap likely involves the expansion of its physical footprint and the integration of next-generation diagnostic technologies to further refine patient outcomes. As the firm transitions from a regional specialist to a more scalable healthcare entity, the focus will remain on optimizing clinical workflows and potentially exploring digital health integrations to support its growing patient base. This capital deployment is expected to solidify the clinic's reputation as a leader in regional immunology, ensuring long-term sustainability and continued excellence in patient-focused medical services.
See full Dr Livas company page
